4//SEC Filing
Celldex Therapeutics, Inc. 4
Accession 0001179110-17-009169
$CLDXCIK 0000744218operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:32 AM ET
Size
9.5 KB
Accession
0001179110-17-009169
Insider Transaction Report
Form 4
Brownlie Keith L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2017-06-15+8,000→ 8,000 totalExercise: $2.32From: 2018-06-15Exp: 2027-06-15→ Common Stock (8,000 underlying) - Award
Common Stock, par value $0.001 per share
2017-06-15+10,000→ 10,000 total - Award
Non-Qualified Stock Option (right to buy)
2017-06-15+15,000→ 15,000 totalExercise: $2.32From: 2018-06-15Exp: 2027-06-15→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]On June 15, 2017, the Company awarded 10,000 shares of Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan subject to time-based forfeiture restrictions.
- [F2]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- [F3]Such option vests in three equal annual installments beginning June 15, 2018.
- [F4]100% of the total amount of shares subject to the Option vests on June 15, 2018.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000744218
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 9:32 AM ET
- Size
- 9.5 KB